Cowan David S DS

Show results for

Unknown (21)
Genomics (1)
Metabolomics (1)

Organisms

Homo sapiens (1)

Repository

biostudies-arrayexpress (1)
MetaboLights (1)

Technology Type

Mass spectrometry (1)

Instrument Platform

Orbitrap Elite (Thermo Scientific) (1)

Publication Date

2016 (1)
2017 (1)

CHEBI ID

CHEBI:131654 (1)
CHEBI:131655 (1)
CHEBI:131658 (1)
CHEBI:131659 (1)
CHEBI:131660 (1)
CHEBI:131661 (1)
CHEBI:131662 (1)
CHEBI:131663 (1)
CHEBI:131665 (1)
CHEBI:131667 (1)
CHEBI:131668 (1)
CHEBI:131687 (1)
CHEBI:131688 (1)
CHEBI:131689 (1)
CHEBI:131690 (1)
CHEBI:131691 (1)
CHEBI:131692 (1)
CHEBI:131693 (1)
CHEBI:131694 (1)
CHEBI:131695 (1)
CHEBI:16919 (1)
CHEBI:17858 (1)
CHEBI:17933 (1)
CHEBI:18186 (1)
CHEBI:20000 (1)
CHEBI:27432 (1)
CHEBI:28940 (1)
CHEBI:34306 (1)
CHEBI:37998 (1)
CHEBI:52450 (1)

Metabolite Name

1-palmitoyl-2-(9,10-epoxystearoyl)phosphatidylcholine (1)
20-Hydroxyeicosatetraenoic acid (1)
25-Hydroxyvitamin-D3 (1)
2a-(Hydroxymethyl)-5a-androstane-3b,17b-diol (1)
3-Dehydroteasterone (1)
5,8,11-Eicosatriynoic acid (1)
8,11,14-Eicosatrien-5-ynoic acid (1)
9(cis)-retinal (Vitamin A) (1)
Acetylcarnitine (1)
Glycolithocholic acid (1)
LysoPC or PCc (PC(24:0/0:0)) (1)
LysoPC(20:4(5Z,8Z,11Z,14Z)) (1)
LysoPC(22:0) (1)
LysoPE(0:0/20:3(5Z,8Z,11Z)) (1)
MG(0:0/16:0/0:0) (1)
MG(18:1(9Z)/0:0/0:0) (1)
PAF C-18 (1)
PC(16:0/20:4(5Z,8Z,10E,14Z)(12OH[S])) (1)
PC(16:0/20:4(6E,8Z,11Z,14Z)(5OH[S])) (1)
PC(16:1(9Z)/2:0) (1)
PC(17:0/18:3(9Z,12Z,15Z)) (1)
PC(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) (1)
PC(O-16:1(9Z)/2:0) (1)
PE(18:0/20:4(5Z,8Z,11Z,14Z)) (1)
PE(18:0/22:5(4Z,7Z,10Z,13Z,16Z)) (1)
PE(18:1(9Z)/0:0) (1)
PE(18:2((9Z,11Z)/18:2(9Z,11Z))[U] (1)
PE(18:2(9Z,12Z)/0:0) (1)
PE(20:2(11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (1)
PS(18:0/22:4(7Z,10Z,13Z,16Z)) (1)

Study type

ChIP-seq (1)

Release Date

2021 (7)
2022 (5)
2025 (3)
2023 (3)
2016 (1)
2024 (1)
2020 (1)
2014 (1)

Previous page
1 / 3
You're on page 1
page 2
page 3
Next page

Sort by:

Relevance

Page size

Treatment of lean and diet-induced obesity (DIO) mice with a novel stable obestatin analogue alters plasma metabolite levels as detected by untargeted LC-MS metabolomics

Introduction: Obestatin is a controversial gastrointestinal peptide purported to have metabolic actions. Objectives: This study investigated whether treatment with a stable obestatin analogue (PEG-OB(Cys10, Cys13) changed plasma metabolite levels firstly in lean and subsequently in diet-induced obes...

2017-07-25 | MTBLS334 | MetaboLights

Bcl11b defect in a human severe combined immunodeficiency with multisystem anomalies

Background: Severe combined immunodeficiency (SCID) is characterized by arrested T lymphocyte production and B lymphocyte dysfunction, resulting in life-threatening infections. Early diagnosis of SCID through population-based newborn screening (NBS) optimizes clinical management and outcomes, and al...

ORGANISM(S): Homo sapiens

2016-07-29 | E-GEOD-84941 | biostudies-arrayexpress

Functional connectivity in autosomal dominant and late-onset Alzheimer disease.

Not available

S-EPMC4240274 | biostudies-literature

Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.

Not available

S-EPMC8725988 | biostudies-literature

Factors Associated with Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional Cohort.

Not available

S-EPMC8734323 | biostudies-literature

Observation of quantum entanglement with top quarks at the ATLAS detector.